Acetyl-Ile-Gly-Leu protects neurons from Aβ1-42 induced toxicity in vitro and in V337M human tau-expressing mice

Life Sciences

Volumn 84, Issue 5-6, 2009, Pages 132-138

  Xiong, Zheng Mei ^a,c   Kitagawa, Kaori ^a   Nishiuchi, Yuji ^b   Kimura, Terutoshi ^b   Nakamura, Tomoyuki ^a   Inagaki, Chiyoko ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Peptide Institute Inc   (Japan)

^c GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid protein; Morris water maze; Phosphatidylinositol 4 kinase type II; Tripeptide

Indexed keywords

ACETYLISOLEUCYLGLYCYLLEUCINAMIDE; ACETYLISOLEUCYLGLYCYLLEUCINE; AMYLOID BETA PROTEIN[1-42]; GLUTAMIC ACID; ISOLEUCYLGLYCYLLEUCINAMIDE; ISOLEUCYLGLYCYLLEUCINE; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 4 KINASE TYPE II; PHOSPHATIDYLINOSITOL KINASE; RECOMBINANT ENZYME; TAU PROTEIN; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ACETYLATION; ALZHEIMER DISEASE; AMIDATION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEARNING DISORDER; MAZE TEST; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RIGHT HEMISPHERE; SPATIAL MEMORY; TRANSGENIC MOUSE;

1-PHOSPHATIDYLINOSITOL 4-KINASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; HIPPOCAMPUS; HUMANS; MAZE LEARNING; MICE; MICE, TRANSGENIC; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TAU PROTEINS;

MUS; MUS MUSCULUS; RATTUS;

EID: 58149459581     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.11.011     Document Type: Article

References (38)

1. Adessi C., Frossard M.J., Boissard C., Fraga S., Bieler S., Ruckle T., Vilbois F., Robinson S.M., Mutter M., Banks W.A., and Soto C. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. The Journal of Biological Chemistry 278 16 (2003) 13905-13911
2. Banks W.A. Delivery of peptides to the brain: emphasis on therapeutic development. Biopolymers 90 5 (2008) 589-594 10.1002/journal.bip.20980
3. Barylko B., Gerber S.H., Binns D.D., Grichine N., Khvotchev M., Südhof T.C., and Albanesi J.P. A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans. The Journal of Biological Chemistry 276 11 (2001) 7705-7708
4. Cancino G.I., Toledo E.M., Leal N.R., Hernandez D.E., Yévenes L.F., Inestrosa N.C., and Alvarez A.R. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's β-amyloid deposits. Brain 131 9 (2008) 2425-2442 10.1093/journal.brain/ awn125
5. Cheung E.C., Melanson-Drapeau L., Cregan S.P., Vanderluit J.L., Ferguson K.L., McIntosh W.C., Park D.S., Bennett S.A., and Slack R.S. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. The Journal of Neuroscience 25 6 (2005) 1324-1334
6. Chin J.H., Ma L., MacTavish D., and Jhamandas J.H. Amyloid β protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors. The Journal of Neuroscience 27 35 (2007) 9262-9269
7. Esposito G., Scuderi C., Savani C., Steardo Jr. L., De Filippis D., Cottone P., Iuvone T., Cuomo V., and Steardo L. Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression. British Journal of Pharmacology 151 8 (2007) 1272-1279
8. Fülöp L., Zarándi M., Datki Z., Soós K., and Penke B. β-amyloid-derived pentapeptide RIIGLa inhibits Aβ1-42 aggregation and toxicity. Biochemical and Biophysical Research Communications 324 1 (2004) 64-69
9. Harkany T., Ábrahám I., Laskay G., Timmerman W., Jost K., Zarándi M., Penke B., Nyakas C., and Luiten P.G. Propionyl-IIGL tetrapeptide antagonizes β-amyloid excitotoxicity in rat nucleus basalis. Neuroreport 10 8 (1999) 1693-1698
10. Hetényi C., Szabó Z., Klement E., Datki Z., Körtvélyesi T., Zarándi M., and Penke B. Pentapeptide amides interfere with the aggregation of β-amyloid peptide of Alzheimer's disease. Biochemical and Biophysical Research Communications 292 4 (2002) 931-936
11. Hresko R.C., Murata H., and Mueckler M. Phosphoinositide-dependent kinase-2 is a distinct protein kinase enriched in a novel cytoskeletal fraction associated with adipocyte plasma membranes. The Journal of Biological Chemistry 278 24 (2003) 21615-21622
12. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., and Westaway D. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408 6815 (2000) 979-982
13. Kwak J.W., Kim H.K., and Chae C.B. Potential lead for an Alzheimer drug: a peptide that blocks intermolecular interaction and amyloid β protein-induced cytotoxicity. Journal of Medicinal Chemistry 49 16 (2006) 4813-4817
14. Lain E., Penke B., Delacourte A., Gündisch D., Schröder H., and Witter B. Effects of Aβ1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the τ-protein and on the α7 nicotinic acetylcholine receptor in vitro. European Journal of Neuroscience 21 4 (2005) 879-888
15. 2+]i in rat astrocytes. Biochemical and Biophysical Research Communications 235 3 (1997) 479-481
16. Lee V.M., and Trojanowski J.Q. Neurodegenerative tauopathies: human disease and transgenic mouse models. Neuron 24 3 (1999) 507-510
17. Lehtonen J.Y., Holopainen J.M., and Kinnunen P.K. Activation of phospholipase A2 by amyloid β-peptides in vitro. Biochemistry 35 29 (1996) 9407-9414
18. Li X.D., Arias E., Jonnala R.R., Mruthinti S., and Buccafusco J.J. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo. Journal of Molecular Neuroscience 27 3 (2005) 325-336
19. Miguel-Hidalgo J.J., and Cacabelos R. β-Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathologica (Berlin) 95 5 (1998) 455-465
20. Mileusnic R., Lancashire C., Clark J., and Rose S.P. Protection against Aβ-induced memory loss by tripeptide D-Arg-L-Glu-L-Arg. Behavioural Pharmacology 18 3 (2007) 231-238
21. Mileusnic R., Lancashire C.L., and Rose S.P. The peptide sequence Arg-Glu-Arg, present in the amyloid precursor protein, protects against memory loss caused by Aβ and acts as a cognitive enhancer. European Journal of Neuroscience 19 7 (2004) 1933-1938
22. Nimmrich V., Grimm C., Draguhn A., Barghorn S., Lehmann A., Schoemaker H., Hillen H., Gross G., Ebert U., and Bruehl C. Amyloid β oligomers (Aβ1-42 globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. The Journal of Neuroscience 28 4 (2008) 788-797
23. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., and Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochemical Research 23 1 (1998) 81-88
24. Ryu J.K., Franciosi S., Sattayaprasert P., Kim S.U., and McLarnon J.G. Minocycline inhibits neuronal death and glial activation induced by β-amyloid peptide in rat hippocampus. Glia 48 1 (2004) 85-90
25. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiological Reviews 81 2 (2001) 741-766
26. Stepanichev M.Y., Zdobnova I.M., Yakovlev A.A., Onufriev M.V., Lazareva N.A., Zarubenko I.I., and Gulyaeva N.V. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid β-peptide (25-35). Journal of Neuroscience Research 71 1 (2003) 110-120
27. Tanemura K., Akagi T., Murayama M., Kikuchi N., Murayama O., Hashikawa T., Yoshiike Y., Park J.M., Matsuda K., Nakao S., Sun X., Sato S., Yamaguchi H., and Takashima A. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiology of Disease 8 6 (2001) 1036-1045
28. Tanemura K., Murayama M., Akagi T., Hashikawa T., Tominaga T., Ichikawa M., Yamaguchi H., and Takashima A. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. The Journal of Neuroscience 22 1 (2002) 133-141
29. Tanzi R.E. The synaptic Aβ hypothesis of Alzheimer disease. Nature Neuroscience 8 8 (2005) 977-979
30. van de Waterbeemd H., and Gifford E. ADMET in silico modelling: towards prediction paradise?. Nature Reviews Drug Discovery 2 3 (2003) 192-204
31. Wu B., Kitagawa K., Liu B., Zhang N.Y., Xiong Z.M., and Inagaki C. Attenuation of amyloid β (Aβ)-induced inhibition of phosphatidylinositol 4-kinase activity by Aβ fragments, Aβ20-29 and Aβ31-35. Neuroscience Letters 396 2 (2006) 148-152
32. -ATPase activity. Life Sciences 72 4-5 (2002) 455-463
33. Wu B., Kitagawa K., Zhang N.Y., Liu B., and Inagaki C. Pathophysiological concentrations of amyloid β proteins directly inhibit rat brain and recombinant human type II phosphatidylinositol 4-kinase activity. Journal of Neurochemistry 91(5) (2004) 1164-1170
34. Xiong Z.M., Kitagawa K., Nishiuchi Y., Kimura T., and Inagaki C. Protective effects of Aβ-derived tripeptide, Aβ32-34, on Aβ1-42-induced phosphatidylinositol 4-kinase inhibition and neurotoxicity. Neuroscience Letters 419 3 (2007) 247-252
35. -ATPase activity in cultured rat hippocampal neurons. Journal of Neurochemistry 78 3 (2001) 569-576
36. Zhang N.Y., Kitagawa K., Hattori N., Nakayama Y., Xiong Z.M., Wu B., Liu B., and Inagaki C. Soybean-derived phosphatidylinositol inhibits in vivo low concentrations of amyloid β protein-induced degeneration of hippocampal neurons in V337M human tau-expressing mice. Life Sciences 80 21 (2007) 1971-1976
37. Zhang N.Y., Kitagawa K., Wu B., and Inagaki C. Soybean-derived phosphatidylinositol recovers amyloid β protein-induced neurotoxicity in cultured rat hippocampal neurons. Neuroscience Letters 350 2 (2003) 105-108
38. Zhang N.Y., Kitagawa K., Wu B., Xiong Z.M., Otani H., and Inagaki C. Chloride-dependency of amyloid β protein-induced enhancement of glutamate neurotoxicity in cultured rat hippocampal neurons. Neuroscience Letters 399 1-2 (2006) 175-180